Translocator Protein Ligand Etifoxine Attenuates MPTP-Induced Neurotoxicity

Parkinson’s disease (PD) is a neurodegenerative disease, but the currently available treatments for this disease are symptomatic treatments. There is evidence that translocator protein (18 kDa) (TSPO) expression is upregulated in some neurodegenerative diseases, and TSPO ligands have obvious neuropr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Qi, Yang, Xiaoxia, Du, Juan, Huang, Huachen, Liu, Wei, Zhao, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172994/
https://www.ncbi.nlm.nih.gov/pubmed/35686060
http://dx.doi.org/10.3389/fnmol.2022.850904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172994/
https://www.ncbi.nlm.nih.gov/pubmed/35686060
http://dx.doi.org/10.3389/fnmol.2022.850904

Ejemplares similares